Form 4: Prestige Consumer Healthcare Executive Exercises and Sells Stock Options
SEC Form 4 Filing
Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare, executed stock options and sold shares on November 12, 2024.
Summary
- Mary Beth Fritz, a Senior Vice President at Prestige Consumer Healthcare, engaged in multiple transactions involving the company's stock on November 12, 2024.
- She exercised options to acquire 6,471 shares at $39.98 per share and simultaneously sold the same amount at $81.99 per share.
- Additionally, she exercised options for 3,414 shares at $54.47 per share and sold them at $81.93 per share.
- Following these transactions, Ms. Fritz directly owns 18,835 shares of common stock and 1,708 employee stock options.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.
Positives
- The exercise of stock options indicates that the executive believes in the company's future prospects.
- The sale of shares at a higher price than the exercise price resulted in a profit for the executive.
Negatives
- The sale of shares by an executive could be interpreted as a lack of confidence in the company's short-term prospects, although this is a common practice for executives.
Risks
- Executive stock sales can sometimes create negative market sentiment, even if they are part of a planned strategy.
- The timing of the sales could be perceived as opportunistic, depending on market conditions.
Industry Context
This is a routine filing related to executive stock transactions and is common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Executive stock option exercises and sales are a standard practice across publicly traded companies.
- The timing and frequency of these transactions are often dictated by vesting schedules and personal financial planning.
- Similar transactions are regularly reported by executives at comparable companies in the consumer healthcare sector.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation activities.
- The sale of shares could slightly increase the supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 08/07/2018 | Date of power of attorney granted to William P'Pool. |
| 05/04/2021 | First vesting date for 2,157 shares of the first option grant. |
| 05/04/2022 | Second vesting date for 2,157 shares of the first option grant. |
| 05/02/2023 | First vesting date for 1,707 shares of the second option grant and third vesting date for 2,157 shares of the first option grant. |
| 05/02/2024 | Second vesting date for 1,707 shares of the second option grant. |
| 05/02/2025 | Third vesting date for 1,708 shares of the second option grant. |
| 11/12/2024 | Date of stock option exercise and sale transactions. |
| 11/14/2024 | Date of filing the Form 4. |
Keywords
Prestige Consumer Healthcare, stock options, insider trading, executive compensation, Form 4, equity securities, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.